DNA extraction service/adaptive biotechnologies/anna pasetto
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700431P
- Awardee
-
Adaptive Biotechnologies Corporation UEI DMW5BNQ331K9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,663
Award facts
- Contract value 100% obligated
- $4,662.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98102, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Adaptive Biotechnologies Corporation for $4,662.50 on July 20, 2017, for DNA extraction services. Place of performance is Seattle, Washington. The order carries a firm fixed-price structure with an ultimate completion date of August 18, 2017.
Quick answers
Who was awarded contract HHSN261201700431P?
HHSN261201700431P was awarded to Adaptive Biotechnologies Corporation by National Cancer Institute (National Institutes of Health) on July 20, 2017.
How much is contract HHSN261201700431P worth?
The government has obligated $4,663 on HHSN261201700431P.
Was contract HHSN261201700431P competed?
The extent of competition for HHSN261201700431P was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award